Torrent Pharmaceuticals

• 

  Torrent Pharma To Acquire Curatio Healthcare For Rs 2,000 Crore

  Torrent Pharmaceuticals on Tuesday said it will acquire Curatio Healthcare for Rs 2,000 crore to strengthen its presence in the dermatology segment.

• 

  Pharma Stocks Gain After Centre Approves Use Of COVID Pill Molnupiravir

  Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday

• 

  Torrent Pharma Surges 10% After Profit Rises 49% In June Quarter

  Torrent Pharma's revenue from US operations declined 1 per cent to Rs 373 crore while constant currency sales came in at $47 million.

• 

  Torrent Pharma To Buy Unichem Labs India Business For Rs 3,600 Crore

  The deal will be funded by internal accruals and bank borrowing, Torrent Pharma said.

• 

  Top 5 Pharma Companies Lose 19,000 Crore In Market Value. Here Is Why

  Analysts say the fresh selloff in the pharmaceutical shares has been triggered after Sun Pharma's US-based subsidiary Taro Pharmaceuticals reported a weak set of earnings in the March quarter.

• 

  Torrent Pharma Shares Tumble 11% As Q2 Net Dips

  The drug firm yesterday reported a 59.33 per cent dip in consolidated net profit to Rs 207 crore for the second quarter.

• 

  Torrent Pharma Q1 Net Slumps 55% To Rs 292 Crore, US Business Hurts

  Drug firm Torrent Pharmaceuticals on Wednesday reported 55.07 per cent fall in consolidated net profit at Rs 292 crore for the June quarter due to a dip in company's US business.

• 

  Torrent Pharma To Acquire Glochem's Vizag-Based Facility

  Torrent Pharmaceuticals on Thursday said it has inked a pact to acquire Glochem Industries' Vizag-based manufacturing facility along with some drug master files.

• 

  Sun Pharma Bets On New Products To Boost US Skincare Products Growth

  India's largest drugmaker Sun Pharmaceutical Industries is banking on the launch of newer and more complex products to offset rising competition in its lucrative U.S. dermatology business, its U.S. chief said.

• 

  Why Torrent Pharma Shares Slumped Despite Stellar Q4

  Torrent Pharma also guided for higher research and development expenditure going forward, which is likely to dent its profitability, analysts said. The management expects R&D costs to scale up to 8 per cent in FY17 from 4 per cent last fiscal.

• 

  Advent, Baxter Set To Submit Bids For India's Gland Pharma: Report

  Global buyout firm Advent International and U.S.-based Baxter International are among suitors preparing to submit separate bids to buy unlisted Indian drugmaker Gland Pharma Ltd, three people with direct knowledge of the matter told Reuters.

• 

  Torrent Pharma Launches Adalimumab Biosimilar in India

  Drug firm Torrent Pharmaceuticals has launched in India its biosimilar Adalimumab, used for the treatment of auto immune disorders, under the brand name 'Adfrar'.

• 

  Basant Maheshwari Explains His Love for Pharma Stocks

  Kolkata-based Mr Maheshwari, who made his fortune from stocks like Page Industries, says broader markets are neither going to go up too much nor fall a lot from current levels (7,856) because of the absence of earnings growth.

• Torrent Pharma Board Approves Zyg Amalgamation

  Torrent Pharmaceuticals on Thursday said its board has given nod to the scheme of amalgamation of its subsidiary Zyg Pharma with the company.

• 

  Elder Pharma Surges 16% on Asset Sale Plans

  Last year, Elder Pharma had sold its branded domestic formulations business in India and Nepal to Torrent Pharmaceuticals for Rs 2,004 crore.